Affordable Access

Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.

Authors
  • Schulte, M
  • Brecht-Krauss, D
  • Werner, M
  • Hartwig, E
  • Sarkar, M R
  • Keppler, P
  • Kotzerke, J
  • Guhlmann, A
  • Delling, G
  • Reske, S N
Type
Published Article
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publication Date
Oct 01, 1999
Volume
40
Issue
10
Pages
1637–1643
Identifiers
PMID: 10520703
Source
Medline
License
Unknown

Abstract

FDG PET provides a promising tool for noninvasive evaluation of neoadjuvant chemotherapy response in osteosarcoma. This could imply consequences for the choice of surgical strategy, because a limb salvage procedure cannot be recommended in patients nonresponsive to preoperative chemotherapy unless wide surgical margins can safely be achieved.

Report this publication

Statistics

Seen <100 times